Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2483-2500

  Zeineh, Michael M ^a   Chen, Yuanxin ^b   Kitzler, Hagen H ^c   Hammond, Robert ^d   Vogel, Hannes ^e   Rutt, Brian K ^a  

^a STANFORD UNIVERSITY   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d WESTERN UNIVERSITY   (Canada)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer; Amyloid; Hippocampus; Iron; Microglia; MRI

Indexed keywords

AMYLOID BETA PROTEIN; IRON; TAU PROTEIN; ACETYLCHOLINESTERASE; AMYLOID; CD163 ANTIGEN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBICULUM; IMAGE PROCESSING; METABOLISM; MYELIN SHEATH; PATHOLOGY; POSTMORTEM CHANGE; VERY ELDERLY;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; MYELIN SHEATH; POSTMORTEM CHANGES; RECEPTORS, CELL SURFACE; TAU PROTEINS;

EID: 84940467351     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.05.022     Document Type: Article

References (50)

1. Adler D.H., Pluta J., Kadivar S., Craige C., Gee J.C., Avants B.B., Yushkevich P.A. Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI. Neuroimage 2014, 84:505-523.
2. Antharam V., Collingwood J.F., Bullivant J.P., Davidson M.R., Chandra S., Mikhaylova A., Finnegan M.E., Batich C., Forder J.R., Dobson J. High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron. Neuroimage 2012, 59:1249-1260.
3. Arnold S.E., Louneva N., Cao K., Wang L.S., Han L.Y., Wolk D.A., Negash S., Leurgans S.E., Schneider J.A., Buchman A.S., Wilson R.S., Bennett D.A. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol. Aging 2013, 34:157-168.
4. Augustinack J.C., Magnain C., Reuter M., van der Kouwe A.J., Boas D., Fischl B. MRI parcellation of exvivo medial temporal lobe. Neuroimage 2014, 93(Pt 2):252-259.
5. Axer M., Amunts K., Grässel D., Palm C., Dammers J., Axer H., Pietrzyk U., Zilles K. Anovel approach to the human connectome: ultra-high resolution mapping of fiber tracts in the brain. Neuroimage 2011, 54:1091-1101.
6. Bao F., Wicklund L., Lacor P.N., Klein W.L., Nordberg A., Marutle A. Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol. Aging 2012, 33:825.e1-825.e13.
7. Benveniste H., Einstein G., Kim K.R., Hulette C., Johnson G.A. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14079-14084.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
9. Chien D.T., Bahri S., Szardenings A.K., Walsh J.C., Mu F., Su M.Y., Shankle W.R., Elizarov A., Kolb H.C. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J.Alzheimers Dis. 2013, 34:457-468.
10. Collingwood J.F., Chong R.K., Kasama T., Cervera-Gontard L., Dunin-Borkowski R.E., Perry G., Posfai M., Siedlak S.L., Simpson E.T., Smith M.A., Dobson J. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J.Alzheimers Dis. 2008, 14:235-245.
11. Colton C.A., Wilson J.G., Everhart A., Wilcock D.M., Puolivali J., Heikkinen T., Oksman J., Jaaskelainen O., Lehtimaki K., Laitinen T., Vartiainen N., Vitek M.P. mNos2 deletion and human NOS2 replacement in Alzheimer disease models. J.Neuropathol. Exp. Neurol. 2014, 73:752-769.
12. Connor J.R., Menzies S.L., St Martin S.M., Mufson E.J. Ahistochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J.Neurosci. Res. 1992, 31:75-83.
13. Davis D.G., Schmitt F.A., Wekstein D.R., Markesbery W.R. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J.Neuropathol. Exp. Neurol. 1999, 58:376-388.
14. de Calignon A., Polydoro M., Suarez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., Pitstick R., Sahara N., Ashe K.H., Carlson G.A., Spires-Jones T.L., Hyman B.T. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73:685-697.
15. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J.Neurol. Sci. 1996, 143:137-142.
16. Dhenain M., Privat N., Duyckaerts C., Jacobs R.E. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed. 2002, 15:197-203.
17. Ding S.L. Comparative anatomy of the prosubiculum, subiculum, presubiculum, postsubiculum, and parasubiculum in human, monkey, and rodent. J.Comp. Neurol. 2013, 521:4145-4162.
18. Edison P., Archer H.A., Gerhard A., Hinz R., Pavese N., Turkheimer F.E., Hammers A., Tai Y.F., Fox N., Kennedy A., Rossor M., Brooks D.J. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 2008, 32:412-419.
19. Everett J., Cespedes E., Shelford L.R., Exley C., Collingwood J.F., Dobson J., van der Laan G., Jenkins C.A., Arenholz E., Telling N.D. Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide beta-amyloid. Inorg. Chem. 2014, 53:2803-2809.
20. Everett J., Cespedes E., Shelford L.R., Exley C., Collingwood J.F., Dobson J., van der Laan G., Jenkins C.A., Arenholz E., Telling N.D. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide beta-amyloid (1-42). J.R. Soc. Interface 2014, 11:20140165.
21. Gallagher J.J., Finnegan M.E., Grehan B., Dobson J., Collingwood J.F., Lynch M.A. Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J.Alzheimers Dis. 2012, 28:147-161.
22. Gandy S., Heppner F.L. Microglia as dynamic and essential components of the amyloid hypothesis. Neuron 2013, 78:575-577.
23. Goedert M., Jakes R. Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 2005, 1739:240-250.
24. Gómez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J.Neurosci. 1996, 16:4491-4500.
25. Griciuc A., Serrano-Pozo A., Parrado A.R., Lesinski A.N., Asselin C.N., Mullin K., Hooli B., Choi S.H., Hyman B.T., Tanzi R.E. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 2013, 78:631-643.
26. Grundke-Iqbal I., Fleming J., Tung Y.C., Lassmann H., Iqbal K., Joshi J.G. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol. 1990, 81:105-110.
27. Lesne S.E. Breaking the code of amyloid-beta oligomers. Int. J. Cell Biol. 2013, 2013:950783.
28. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J.Neurol. Sci. 1998, 158:47-52.
29. McGeer P.L., McGeer E.G. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013, 126:479-497.
30. Meadowcroft M.D., Connor J.R., Smith M.B., Yang Q.X. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J.Magn. Reson. Imaging 2009, 29:997-1007.
31. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
32. Niedowicz D.M., Beckett T.L., Matveev S., Weidner A.M., Baig I., Kryscio R.J., Mendiondo M.S., LeVine H., Keller J.N., Murphy M.P. Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease. Ann. Neurol. 2012, 72:564-570.
33. Pankhurst Q., Hautot D., Khan N., Dobson J. Increased levels of magnetic iron compounds in Alzheimer's disease. J.Alzheimers Dis. 2008, 13:49-52.
34. Preibisch S., Saalfeld S., Tomancak P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 2009, 25:1463-1465.
35. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., Ferrer I., Arranz R., Patiño C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J.Struct. Biol. 2006, 153:42-54.
36. Quintana C., Cowley J.M., Marhic C. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. J.Struct. Biol. 2004, 147:166-178.
37. Rosene D., Van Hoesen G. The hippocampal formation of the primate brain. A review of some comparative aspects of cytoarchitecture and connections. Cerebral Cortex Further aspects of cortical function, including hippocampus 1987, vol. 6:345-456. Plenum, New York.
38. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A. Fiji: an open-source platform for biological-image analysis. Nat. Methods 2012, 9:676-682.
39. Selkoe D.J. Biochemistry and Molecular Biology of Amyloid β-Protein and the Mechanism of Alzheimer's Disease. Handb Clin Neurol. 2008, 89:245-260.
40. Sheng J.G., Mrak R.E., Griffin W.S. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 1995, 21:290-301.
41. Smith M.A., Harris P.L., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9866-9868.
42. Spires-Jones T.L., Hyman B.T. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 2014, 82:756-771.
43. Tanzi R.E. The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:1-10.
44. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
45. Thal D.R., Rüb U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., Braak E., Braak H. Sequence of Abeta-protein deposition in the human medial temporal lobe. J.Neuropathol. Exp. Neurol. 2000, 59:733-748.
46. Tomic J.L., Pensalfini A., Head E., Glabe C.G. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol. Dis. 2009, 35:352-358.
47. Venneti S., Lopresti B.J., Wiley C.A. Molecular imaging of microglia/macrophages in the brain. Glia 2013, 61:10-23.
48. Witter M.P., Amaral D.G. Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex. J.Comp. Neurol. 1991, 307:437-459.
49. Yokokura M., Mori N., Yagi S., Yoshikawa E., Kikuchi M., Yoshihara Y., Wakuda T., Sugihara G., Takebayashi K., Suda S., Iwata Y., Ueki T., Tsuchiya K.J., Suzuki K., Nakamura K., Ouchi Y. Invivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:343-351.
50. Zhang B., Gaiteri C., Bodea L.G., Wang Z., McElwee J., Podtelezhnikov A.A., Zhang C., Xie T., Tran L., Dobrin R., Fluder E., Clurman B., Melquist S., Narayanan M., Suver C., Shah H., Mahajan M., Gillis T., Mysore J., MacDonald M.E., Lamb J.R., Bennett D.A., Molony C., Stone D.J., Gudnason V., Myers A.J., Schadt E.E., Neumann H., Zhu J., Emilsson V. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013, 153:707-720.